Having been diagnosed with a grade 4 glioblastoma I received radiotherapy and chemotherapy treatment. A molecular profiling was recommended via staff at LINK Medical. The Caris profiling was done with speed and efficiency and the findings identified a unique NTRK gene fusion which led to recommendations such as larotrectinib. The detection of the gene fusion, which is extremely rare, has made a great difference to my potential treatment options.